[1]
Blau K. Chromatographic methods for the study of amines from biological material. Biochem J, 1961, 80: 193-200.
DOI: 10.1042/bj0800193
Google Scholar
[2]
Baba S, Watanabe Y, Gejyo F, et al. High-performance liquid chromatographic determination of serum aliphatic amines in chronic renal failure. Clin Chim Acta, 1984, 136: 49-56.
DOI: 10.1016/0009-8981(84)90246-8
Google Scholar
[3]
Asatoor AM, Kerr DNS. Amines in blood and urine in relation to liver disease. Clin Chim Acta , 1961, 6: 149-156.
DOI: 10.1016/0009-8981(61)90078-x
Google Scholar
[4]
Lyles GA, McDougall SA. The enhanced daily excretion of urinary methylamine in rats treated with semicarbazide or hydralazine may be related to the inhibition of semicarbazide-sensitive amine oxidase activities. Pharm Pharmacol J, 1989, 41: 97-100.
DOI: 10.1111/j.2042-7158.1989.tb06401.x
Google Scholar
[5]
Smith AD, Jepson JB. Chromatography of urinary and tissue amines and amino alcohols as 2, 4-dinitrophenyl derivatives prepared with 2-nitrobenzenesulfonic acid. Anal Biochem, 1967, 18: 36-45.
DOI: 10.1016/0003-2697(67)90053-x
Google Scholar
[6]
Schayer RW, Smiley LR, Kaplan HE. The metabolism of epinephrine containing isotopic carbon, Biol Chem J, 1952, 198: 545-551.
DOI: 10.1016/s0021-9258(18)55509-5
Google Scholar
[7]
Dar MS, Morselli PL, Bowman ER. The enzymatic systems involved in the mammalian metabolism of methylamine. Gen Pharmacol, 1985, 16: 557-560.
DOI: 10.1016/0306-3623(85)90142-9
Google Scholar
[8]
Zeisel SH, Dacosta KA. Increase in human exposure to methylamine precursors of N-nitrosamines after eating fish. Cancer Res, 1986, 46: 6136-6138.
Google Scholar
[9]
US Dept Health and Human Services Constituents of tobacco smoke. USPHS Publication No. 82-50179, 1982, 322.
Google Scholar
[10]
Bolt HM . Experimental toxicology of formaldehyde. J Cancer Res Clin Oncol , 1987, 113: 305–309.
Google Scholar
[11]
Nilsson SE, Tryding N, Tufvesson G . Serum monoamine oxidase in diabetes mellitus and some other internal diseases. Acta Med Scand 1968, 184: 105–108.
DOI: 10.1111/j.0954-6820.1968.tb02429.x
Google Scholar
[12]
Yuen CT, Easton D, Misch K, et al. Increased activity of serum amine oxidase in granuloma annulare, necrobiosis lipoidics and diabetes. Br J Dermatol , 1987, 11: 643–649.
DOI: 10.1111/j.1365-2133.1987.tb05897.x
Google Scholar
[13]
Boomsma F, Derkx FH, van den Meiracker AH, et al. Plasma semicarbazide-sensitive amine oxidase activity is elevated in diabetes mellitus and correlates with glycosylated haemoglobin. Clin Sci, 1995, 88: 675– 679.
DOI: 10.1042/cs0880675
Google Scholar
[14]
Garpenstrand H, Ekblom J, Backlund LB, et al. Elevated plasma semicarbazide-sensitive amine oxidase (SSAO) activity in type 2 diabetes mellitus complicated by retinopathy. Diabet Med, 1999, 16: 514–521.
DOI: 10.1046/j.1464-5491.1999.00103.x
Google Scholar
[15]
Ishizaki F. Plasma benzylamine oxidase activity in cerebrovascular disease. Eur Neurol, 1990, 30: 104–107.
DOI: 10.1159/000117321
Google Scholar
[16]
Boomsma F, van Veldhuisen DJ, de Kam PJ, et al. Plasma semicarbazide-sensitive amine oxidase is elevated in patients with congestive heart failure. Cardiovasc Res, 1997, 33: 387–391.
DOI: 10.1016/s0008-6363(96)00209-x
Google Scholar
[17]
Yu PH, Deng YL. Endogenous formaldehyde as a potential factor of vulnerability of atherosclerosis: involvement of semicarbazide-sensitive amine oxidase-mediated methylamine turnover. Atherosclerosis, 1998, 140: 357-363.
DOI: 10.1016/s0021-9150(98)00142-7
Google Scholar
[18]
Helander A, Tottmar O. Metabolism of biogenic aldehydes in isolated human blood cells, platelets and in plasma. Biochem. Pharmacol, 1987, 36: 1077-1082.
DOI: 10.1016/0006-2952(87)90417-5
Google Scholar
[19]
Malorny GN, Rietbrock N, Schneider M. The oxidation of formaldehyde to formic acid in the blood and contribution to the metabolism of formaldehyde, Naunynschmiedeberg's Arch. Exp. Pathol. Pharmakol, 1965, 250: 419-436.
Google Scholar
[20]
Gubisne-Haberle D, Hill W, Kazachkov M, et al. Protein cross- linkage induced by formaldehyde derived from semicarbazide-sensitive amine oxidase-mediated deamination of methylamine. J Pharmacol Exp Ther, 2004, 310: 1125-1132.
DOI: 10.1124/jpet.104.068601
Google Scholar